About: Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of efficacious treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase III clinical trial. The company has a collaboration with Tessara Therapeutics. Invex Therapeutics Ltd was incorporated in 2019 and is based in Perth, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.12 (+14.29%)
IXC ASX INVEX Therapeutics Ltd
INVEX Therapeutics Ltd share price
IXC price activity
Last Price
$0.120
Change (24hr)
0.02 AUD (14.29%)
Volume
475.68K
Volume (4w avg)
-
Open
$0.11
Day Range
$0.11 - $0.12
Previous Close
$0.11
Last Trade
26 Oct, 5:10 am GMT+0
Delayed
26 Oct, 5:10 am GMT+0
IXC price performance
Delayed
26 Oct, 5:10 am GMT+0
IXC Market Signals